CRYOLIFE, INC.

Basic Information

1655 ROBERTS BLVD, NW
KENNESAW, GA, 30144

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. N/A

    Amount: $0.00

    N/A

    SBIR Phase I 2000 Department of Health and Human Services
  2. N/A

    Amount: $314,781.00

    N/A

    SBIR Phase II 2000 Department of Health and Human Services
  3. ENGINEERED HEART VALVE--FLOW AND FIBROBLAST FUNCTION

    Amount: $744,296.00

    N/A

    SBIR Phase II 1997 Department of Health and Human Services
  4. CRYOPRESERVED ARTERIES AS ALLOGRAFT VASCULAR CONDUIT

    Amount: $99,984.00

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
  5. ENGINEERED HEART VALVE--FLOW AND FIBROBLAST FUNCTION

    Amount: $99,484.00

    N/A

    SBIR Phase I 1996 Department of Health and Human Services
  6. Bioadhesive for Surgery and Wound Repair

    Amount: $99,782.00

    We will develop a strong, safe, easy-to-use, biocompatible, and degradable bioadhesive for surgicalrequiring tissue sealing and closure. This bioadhesive will have the potential to streamline commonwe ...

    SBIR Phase I 1995 Department of Health and Human Services
  7. Xenogeneic Arterial Bypass Graft

    Amount: $73,360.00

    Although the autogenous saphenous vein is the vessel typically utilized in arterial bypass procedurarise in which it is not possible to use this vein, demanding an alternative method. The investigatof ...

    SBIR Phase I 1995 Department of Health and Human Services
  8. Fascia Lata Xenograft for ACL Replacement

    Amount: $91,680.00

    Autologous patellar tendon grafts are the current gold standard for replacement of irreparable anteligaments. Allogeneic tissue grafts are the only accepted alternative to autologous grafts and theysu ...

    SBIR Phase I 1995 Department of Health and Human Services
  9. Xenograft Heart Valves--Biomechanics/Collagen Structure

    Amount: $74,576.00

    Though allograft human aortic valves are preferred for transplantation by virtue of their lowthrombogenicity and immunogenicity, superior hemodynamic performance, and extended durability, onlyabout 2, ...

    SBIR Phase I 1994 Department of Health and Human Services
  10. DEVELOPMENT OF A FIBRIN SEALANT DELIVERY METHOD

    Amount: $500,000.00

    FIBRIN SEALANT HAS MANY APPLICATIONS IN SURGERY. MIXING AND DELIVERY OF THE MAJOR COMPONENTS, FIBRINOGEN AND THROMBIN, IS CURRENTLY ACHIEVED USING TWO SYRINGES OR SPRAY CONTAINERS DISPENSED ALTERNATEL ...

    SBIR Phase II 1993 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government